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INTRODUCTION 
Although uterine bleeding is a normal physiologic episodic 
occurrence for most women, its characteristics nevertheless vary 
considerably. The broad range of normal variation causes difficulty in 
identifying abnormal patterns. The problem is that uterine bleeding 
has a wide range of diagnostic possibilities and confusion is generated 
when review and reports fail to outline the diagnostic evaluation of the 
patient who presents with abnormal uterine bleeding patterns. 
Goals of clinical management are primarily dependent upon 
attaining a correct etiological diagnosis. The history, physical and 
pelvic examination attempt to determine the site of the bleeding and 
its source. Information gathered from this will suggest what direction 
the investigation would take. Traditionally Dilatation and Curettage 
and Ultrasonography were the most common investigations employed 
in the evaluation of the causes of AUB1. 
TVS is useful in detecting endometrial thickness and 
morphology as well as the regularity of endo myometrial border, well 
tolerated by patients but sessile or pedunculated lesions of 
endometrium and malignant disease cannot be excluded. As an 
investigation of AUB, it is recommended by RCOG and ACOG in 
1994. 
Addition of color Doppler and 3D imaging29 leads to diagnostic 
accuracy, The use of 3D SHG speeds the procedure and greatly helps 
in the diagnosis of submucous leiomyomas.  
The use of TVS assisted gynecological surgery has emerged as 
a tool for providing high resolution image of cervical canal and uterine 
cavity during all the stages of procedure and provides improved 
indication of the procedure’s endpoint. 
Hysteroscopy has ushered a new era in the evaluation of AUB. 
By direct visualization of the uterine cavity it is able to pin point the 
etiology in the majority of the cases. It can accurately detect 
endometrial hyperplasia and aids in the early diagnosis of endometrial 
carcinoma and uterine polyps. 
This study conducted at the institute of obstetrics and 
gynecology Chennai during the year 2009-2010 compares the efficacy 
of hysteroscopy and trans vaginal sonography in the evaluation of 
AUB in reproductive age group. 
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AIM OF THE STUDY 
 
This study conducted at Institute of obstetrics and gynecology 
Chennai during the year 2009-10 compares the efficacy of 
hysteroscopy and transvaginal sonography in diagnosing the 
pathology in patients with  AUB. The hysteroscopic and sonographic 
findings are correlated with the histopathological diagnosis of 
endometrium obtained by curettage. 
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REVIEW OF LITERATURE 
 
HISTORICAL REVIEW: 
“A vigilant eye in the uterine cavity is better than numerous 
blind curettages”, quoted Lindmann2, about the future of 
hysteroscopy. 
Until the beginning of the 20th century, this possibility existed 
only for external orifices. Archigenes of Apameia already had a grasp 
of illumination procedures, “et hoc ad clarem lucem siat.” 
Subsequently anal and vaginal specula were developed from simple 
tubes to more complex instruments for dilatation and observation. 
Various methods were devised using systems of concave mirrors and 
lenses, to collect and focus light from natural and artificial sources and 
direct it into a cavity2. 
History of endoscopy really begins in the early years of the 19th 
century. In 1805, Bozzini (1773-1809) constructed a device called a 
light conductor that enabled him to inspect various passages and body 
cavities. In 1864, Aubinais observed a baby’s head emerge from the 
cervix with a tube he inserted into the vagina, and for this reason he 
has been described incorrectly as the first hysteroscopist. 
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The first hysteroscopy (also called as metroscopy or 
uteroscopy) was described in 1869 by Pantaleoni3. Polypoid 
endometrial growths were observed by him. Pantaleoni used reflected 
candle from a concave mirror to illuminate the uterine cavity. 
In 1895 Ernest Bumm from Germany reported to the Vienna 
Congress about his experiments with uterine endoscope. He was able 
to examine changes inside uterine mucosa, granulation, ulcers and 
growth. Frequent bleeding was a major problem that disrupted his 
examination of the cavity.  
In 1893, Morris2 used a straight silver and brass tube. He 
observed tubal ostia and endometrium. Bleeding and mucous 
obstructed his vision. So a new type of hysteroscopy was proposed by 
Beutner5 in 1898 which was equipped with water sprinkler. 
In 1907, David demonstrated the first contact hysteroscopy, 
which was useful for diagnosis of uterine disorders. In 1914, 
Heineberg6 devised a system for irrigating the uterine cavity to rinse 
off the blood that often covered the lens and hindered the lesion. In 
1925, Rubin7 insufflated the uterine cavity with CO2 instead of water. 
In 1927, Mikulicz-Radecki and Freund2 collaborated to produce a 
‘curettoscope’ with biopsy taking capability and corneal electro 
coagulation. 
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In 1928, Gauss8 succeeded in taking intrauterine photography. 
In 1934, Schroeder collected important data on the intrauterine 
pressure during hysteroscopy. He succeeded in developing an 
instrument with an excellent forward viewing optical system. It thus 
became possible to inspect large areas of the cavity and to observe 
three-dimensional views. 
Other pioneers of hysteroscopy during these years (1934-1943) 
were Bank, Schack and Segond9. Norment10 in 1943 reported a new 
technique that called for transparent rubber balloon mounted on the tip 
of hysteroscope and illumination provided by an external light. 
Mohri11 and colleagues (1953-1978) reported on the possibility of 
embryoscopy and also introduced the first tubaloscope. 
Englund12 and colleagues recommended hysteroscopy for 
uterine bleeding in 1957. In 1962, Sinander studied endometrial 
carcinoma using silastic balloon. A new era in hysteroscopy began 
with the introduction of viscous fluid as media for distending the 
uterine cavity. Menken13 in 1968 used Loviscol, a poly-vinyl 
pyrrolidine as distension media. Edstrom and Fernstrom used 
Dextran (32%); Lindemann14 used CO2 as distending media in 1972. 
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In 1979 Baggish15 reported his first experience with contact 
hysteroscope. In 1981, Hamou16 demonstrated microhysteroscope, 
modern panoramic hysteroscopy with a variation of contact 
hysteroscopy in a single endoscope. Panoramic hysteroscope and all 
channel operating sheath was described by Baggish in 1987. Recently 
Baggish also developed a special dual channel hysteroscope for 
intrauterine laser surgery17. 
Hysteroscopic operative removal of myoma has been advocated 
as a more efficacious and safe procedure. Recently most hysteroscopic 
surgeons have preferred to perform myomectomy utilizing Hyskon as 
the distending medium, because of its lack of miscibility with blood 
and optical clarity. Although no hysteroscopic method of tubal 
occlusion can be accepted as practical at present, it seems reasonable 
to accept that the hysteroscopic approach remains promising. 
M. M. Tahir et al, M. A. Bigrigg et al, J. J. Browning et al, 
T. Brookes et al, Phillip A. Smith27 et al, conducted a randomized 
controlled trial in 1999 comparing TVS, outpatient hysteroscopy and 
endometrial biopsy with inpatient hysteroscopy and curettage. They 
concluded that TVS and endometrial biopsy can safely be used as the 
initial investigations in the management of AUB. Hysteroscopy can be 
used as a second line investigation. 
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Garuti et al18 in 2001 conducted a study to estimate the 
accuracy of hysteroscopy in predicting endometrial histopathology. 
1500 women with AUB were studied. Hysteroscopy showed 
sensitivity, specificity, NPV, and PPV of 94.2%, 88.8%, 96.3%, and 
83.1% respectively. Highest accuracy was in diagnosing endometrial 
polyps, with sensitivity of 95.3%, specificity 95.4%, PPV 98.9% and 
NPV 81.7%. 
Madan and Al-Jufairi19 in 2001 retrospectively studied 556 
cases of AUB, who underwent hysteroscopy and D&C. 53, were 
diagnosed to have endometrial polyps hysteroscopically, however 
only 13 pts were confirmed to have polyps histologically. 
Hysteroscopy was highly specific for diagnosis of both endometrial 
hyperplasia (85%) and endometrial carcinoma (99.5%); however the 
sensitivity of hysteroscopy for diagnosing endometrial cancer was 
40% and 30% for endometrial hyperplasia. 
HKCOG GUIDELINES NO. 5 MAY 2001   
Transvaginal sonography and endometrial biopsy are the 
preferred first line methods of assessing the endometrium. 
Hysteroscopy / Vabra aspiration or hysteroscopy/D&C are the 
alternative methods of investigation if so required. Routine first line 
D&C should be discouraged.  
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Clark20 in 2002 conducted study on the accuracy of 
hysteroscopy in the diagnosis of endometrial cancer and hyperplasia. 
They concluded that diagnostic accuracy of hysteroscopy is high for 
endometrial cancer, but only moderate for endometrial diseases. 
Bain21 in 2002 evaluated and compared the clinical benefit of 
additional out-patient hysteroscopy over traditional vaginal 
examination and endometrial biopsy in unselected pre-menopausal 
women and 370 women were recruited in the study and he concluded 
that out-patient diagnostic hysteroscopy is an acceptable procedure 
and may give more reassurances. It does not influence clinical 
management, especially with respect to hysterectomy rate. Out-patient 
hysteroscopy may be useful in selected cases, but when performed in a 
non-selective manner, it has little influence on clinical management 
and increases costs. 
Gianninoto22 in 2003 conducted a retrospective study of 
diagnostic hysteroscopy in AUB and concluded that ambulatory 
hysteroscopy was shown to be a simple, safe, well tolerated and 
reliable procedure in the diagnosis of AUB across all age-groups and 
its wide spread use can drastically reduce the need for conventional 
curettage, thereby increasing patient satisfaction and lowering costs. 
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 deWit and Vleugels23 in 2003 evaluated 1045 hysteroscopies 
performed over 6 years retrospectively. Normal cavity was found in 
54.2%. Most common abnormal findings were fibroids (21%) and 
endometrial polyps (14.4%). Hysteroscopically diagnosed hyperplasia 
of the endometrium was confirmed in only less than half the cases. 
Endometrial carcinoma was suspected on hysteroscopic view in 2 
cases of a total of 7 proven cases. Diagnostic hysteroscopy is a 
valuable tool in diagnosing structural intra-cavital pathology, very 
suitable for out-patient clinic.  
Jaiswar Shyam Pyari et al, Sachan Rekha et al, Srivastava 
PK et al, Madhumati Goel et al, Monika Pandey24 et al in 2005 
conducted a prospective study at King George Medical University, 
Lucknow  to evaluate the diagnostic efficacy of  hysteroscopy, TVS 
and HPE in cases of AUB. Most common symptoms were 
menorrhagia (40%), metrorrhagia (18%), menometrorrhagia (14%), 
and polymenorrhea (14%). Compared to hysteroscopy, TVS had a 
sensitivity of 78.15% 
Epstein E et al, Ramirez A et al, Skoog L et al, Valentin L25 
et al in 2005 conducted a prospective study at the university hospital, 
Sweden to determine the ability of TVS, to detect focal lesions in the 
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uterine cavity in women with PMB and endometrium > 5 mm, and the 
accuracy of conventional USG, saline contrast sonohysterography and 
hysteroscopy to diagnose polyps, myomas and uterine malignancy. 
Saline contrast sonohysterography and hysteroscopy both had a 
sensitivity of approximately 80% with regard to diagnosing 
endometrial polyps whereas conventional ultrasound had a sensitivity 
of 49%; false-positive rate, 19%. Hysteroscopy was superior to both 
with regard to discriminating between benign and malignant lesions 
(sensitivity, 84%, 44%, and 60%; false-positive rate, 15%, 6% and 
10%, respectively).   
Mojgan Barati, et al, Sara Masihi, et al, Farideh Moramezi, 
et al, Shabnam Salemi26 et al  Clinical trial study conducted from 
Mar-05 to Mar-07, at Ahwaz Imam Khomayni hospital., 147 patients 
with normal TVS entered the study and were considered for outpatient 
hysteroscopy. 
Majority was over 40 years old (96 women). 115 patients 
(78.2%) had normal and 32 patients (21.8%) had abnormal 
Hysteroscopic results. 116 patients (78.8%) had normal and 31 
patients (21.2%) had abnormal pathologic results; moreover, cervical 
canal polyp was the most common lesion hysteroscopically and 
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pathologically in all groups. They concluded that in patients with 
AUB and normal TVS, hysteroscopy can be used as the second step 
procedure.   
Tajossadat Allameh et al, Fereshteh Mohammadizadeh28et 
al in 2007 conducted a prospective, descriptive analytic study on 105 
patients with AUB at the Isfahan University, Iran to define the 
diagnostic value of hysteroscopy in AUB compared to pathologic 
findings and showed 100% sensitivity, 80.5% specificity, 88.9% 
positive predictive value (PPV) and 100% negative predictive value 
(NPV) and concluded that hysteroscopy can be used as the first line 
diagnostic method. However hysteroscopy without directed biopsy has 
insufficient value for diagnosing endometrial hyperplasia. 
Alcázar JL et al, Laparte29 C et al in 2009 conducted a 
comparative study of TVS and hysteroscopy in post menopausal 
bleeding at the University of Navarra, Spain, to assess the accuracy of 
TVS and hysteroscopy for diagnosing endometrial pathology. 
Considering a cutoff value of < or = 5 mm as normal, TVS showed 
normal findings in 50% of patients and abnormal in other 50%. 
Sensitivity, specificity, and PPV and NPV for TVS and hysteroscopy 
were 100, 60.8, 35.7, and 100% and 100, 89.4, 71.4, and 100%, 
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respectively. Both methods were highly sensitive, but hysteroscopy 
was more specific than TVS. 
STUDIES ON TRANSVAGINAL ULTRASOUND 
 
Mark H. Emanuel30 et al in 1993 conducted a comparative 
study to determine the diagnostic value of TVS in patients with AUB. 
Findings were compared with the final diagnosis established by 
diagnostic hysteroscopy and histologic examination. TVS 
demonstrated a sensitivity of 0.96 and a specificity of 0.89. Its use 
could be implemented as a routine first-step procedure in patients with 
AUB, and it selects those in need of further diagnostic evaluation in 
the case of an abnormal or inconclusive sonogram 
Garuti G et al, Sambruni I et al, Cellani F et al, Garzia D et 
al, Alleva P et al, Luerti M31 et al in 1999 conducted a study in the 
Hospital of Lodi, Italy, to evaluate the accuracy of hysteroscopy and 
TVS based on HPE report from endometrial specimen, in menopausal 
women with uterine bleeding.  TVS showed sensitivity of 95.1%, 
specificity of 54.8% and positive predictive value of 63.7% at a cut-
off limit of 4 mm. With a cut-off limit of 8 mm the corresponding 
figures were 83.8%, 81.3% and 79.4%. Hysteroscopy demonstrated a 
sensitivity of 96.5%, specificity of 93.6% and positive predictive 
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value of 92.6%. Hysteroscopy is a more accurate technique than TVS 
because of better specificity .  
Tahir M M27 et al in 1999, in their randomized control trial 
concluded that TVS and endometrial biopsy can safely be used as the 
initial investigation in the management of AUB. 
Diaa El-Mowafi et al, Ahmed Farid et al and Ahmed El-
Badawi32 et al in 1996 conducted a prospective study at the Benha 
Faculty of Medicine, Egypt to compare TVS and hysteroscopy with 
HPE results of D&C.  
TVS gave a sensitivity and specificity of 73.9% and 73.7% and 
a PPV, NPV and efficacy of 77.3%, 70% and 73.8% respectively. 
Hysteroscopy gave a sensitivity and specificity of 78.3% and 84.2% 
and a PPV, NPV and efficacy of 85.7%, 76.2% and 81% respectively. 
This study shows that TVS is easy, relatively cheap, needs no 
anesthesia and non - invasive it can be used as the first diagnostic step.   
JONES, K. D. ET AL, JERMY, K ET AL. AND BOURNE33 T. H 
ET AL IN 2002  
A review study conducted at the ‘one-stop’ clinic of AUB 
reported that the combination of TVS with SIS has made ultrasound 
without hysteroscopy a potential primary diagnostic tool. Compared  
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FIG : 1 HYSTEROSCOPIC INSTRUMENTS 
FIG 2:  NORMAL TVS PICTURE OF UTERINE CAVITY 
with TVS alone, TVS plus SIS increases the sensitivity from 67% to 
87%, the specificity from 89% to 91%, the positive predictive value 
from 88% to 92% and the negative predictive value from 71% to 86%.  
HYSTEROSCOPY 
Hysteroscopy is a technique in which an endoscope is 
introduced in the cervical canal and uterine cavity through vagina for 
visualization of endocervical canal and uterine cavity and fibro optical 
transmitted light provides illumination, distension of uterine cavity is 
obtained with appropriate media and video camera attached to the 
telescope allows monitoring on a television screen with magnification. 
INSTRUMENTATION IN HYSTEROSCOPY 
1. Optics 
2. Distension media 
3. Light source 
4. Surgical instruments: 
¾ Speculum,Vulsellum,Cervical dilators, Uterine sound, Curette    
 
OPTICS 
In most modern endoscopes the illuminating light is carried to 
the object by an optical fibre bundle. 
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DIFFERENT TYPES OF HYSTEROSCOPES ARE BEING 
EVOLVED: 
1.  Conventional panoramic hysteroscope 34 
2.  Contact hysteroscope 35 
3.  Microhysteroscope 
4.  Portable out-patient hysteroscopes 
5.  Specialised hysteroscopes 
The Flexible Hysteroscope: 
The Hysteroser: 
DISTENSION MEDIA 
Common agents used for distension includes gas and liquids. 
GAS: CO2 
The only gas commonly used is CO2 which has been used since 
1920, when it was used by Rubin for tubal perflation.. An intrauterine 
pressure of 200mm of Hg should not be exceeded and the flow of the 
gas should be regulated to a limit of 100ml per minute36. 
Advantages of CO2: 
• Relatively nontoxic 
• Rapidly absorbed 
• Ideal for office hysteroscopy36 
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Disadvantages of CO2: 
• Air bubbles need to be avoided 
• Bleeding obscures the field 
• Expensive insufflating equipment 
• Perfect cervical occlusion required to avoid gas   
    escape36. 
LIQUID DISTENSION MEDIA 
Hyskon: 
32% Dextran-70 in 10% Dextrose. This solution is too viscous 
to be instilled by gravity and tends to clog the pump, therefore 
instilled from 20cc or 50cc syringe. 
Advantages: 
• Colourless, safe, viscid hypertonic solution. 
• Can be used universally with electrosurgical devices, lasers 
and conventional equipments. 
• Immiscible with blood, therefore excellent visualization 
even during active bleeding. Therefore definite site of 
bleeding can be known perfectly. 
• Unlikely to produce volume overload37. 
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Disadvantages: 
• Not easily available and expensive 
• May precipitate allergic reactions including anaphylaxis 
• Instruments needs immediate cleaning because of its 
solidification on drying 
• Difficult through 5mm sheath 
• Can cause Pulmonary edema 37 
5% Dextrose37 
Advantages:  
• Easy availability 
• Rapid absorption 
Disadvantages: 
• Not for office use 
• Vision not so good 
• Large quantity of dextrose is needed 
• Retrograde leak 
• Miscible with blood 
Normal Saline and Ringer lactate37: 
Advantages: 
• Cheap, readily available, non sticky 
• Isotonic medium 
• Acts as an effective medium when Nd YAG laser or KTP 
laser, bipolar electrode and mechanical devices are the 
accessories of choice. 
• Requires minimum equipment for satisfactory delivery. 
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Disadvantages: 
• Not to be used with electro surgery because of its electrical 
conductance. 
• Mixes with blood and reduces vision 
• Can cause water intoxication 
• Retrograde leak is a possibility 
Glycine 1.5% and Sorbitol 3% 37: 
• Non viscous, non sticky and clear solutions 
• Useful for monopolar electrosurgical devices 
• Hypo-osmolar media: can cause acute hyponatremic state 
• Does not easily mix with blood 
• Metabolites of Glycine are toxic to CNS, causes 
demyelination 
• Intravasation causes nausea, vertigo, high output cardiac 
failure   
METHODS OF INFUSION 
1.  Pressure cuff: Constant pressure is not maintained as 
pressure decreases as bag empties 
2.  Mechanical / Automated pumps: These have pre-adjusted 
flow rates and pressure settings. 
3.  Gravity: By mounting the bag on an intravenous pole 
enclosed in a wide BP cuff inflated to a pressure of 80-100 
mm of Hg. Height of the bag determines the pressure. 
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LIGHT SOURCE 
Three general types of light generators are available38 
• Tungsten 
• Metal Halide 
• Xenon 
 INDICATIONS FOR HYSTEROSCOPY 39 
1.  Evaluation of unexplained AUB in pre-menopausal or post-
menopausal patients. 
2.  Diagnosis and trans-cervical hysteroscopic removal of 
suspected sub mucous leiomyoma or endometrial polyp. 
3.  Location and retrieval of ‘lost’ IUD or other foreign body 
4.  Evaluation of primary and secondary infertility including 
confirmation of abnormal hysterogram 
5.  Diagnosis and surgical treatment of intra-uterine adhesions. 
6.  Exploration of endo-cervical canal, internal cervical os and 
uterine cavity in patients with repeated miscarriages. 
7.  Evaluation of patients with failed first-trimester elective 
abortions. 
8.  Trans-cervical division of small uterine septae. 
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9.  Assessment of uterine wall defects following surgical 
procedure such as: myomectomy, caesarean section and 
hysterotomy. 
CONTRA-INDICATIONS FOR HYSTEROSCOPY 39 
ABSOLUTE: 
1.  Recent or existing uterine infection: Cervical or uterine 
infection must be ruled out prior to hysteroscopy. Patients 
with recent uterine or adnexal infection should not undergo 
the procedure which could exacerbate an infection.   
2.  Pregnancy: Hysteroscopy should not be undertaken in 
pregnant patients who desire to continue pregnancy, unless 
the value of information gained outweighs the potential 
dangers of infection or pregnancy interruption. 
3.  Profuse uterine bleeding: In patients with excessive uterine 
bleeding hysteroscopy cannot be performed satisfactorily 
regardless of the distension medium used. 
4.  Cervical malignancy: Because of the possibility of 
spreading the disease due to cervical manipulation, patients 
with known carcinoma cervix should be excluded. 
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RELATIVE: 
1.  Adenocarcinoma of endometrium, when the operator is not 
familiar with this disease 
2.  Marked cervical stenosis 
3.  Operator unfamiliarity with instrumentation and technique. 
COMPLICATIONS, PREVENTION AND MANAGEMENT40 
When the appropriate technique and selection of patients are 
observed, hysteroscopy has practically no complications. However 
because some blind manipulations are required in sounding the uterine 
cavity or dilating the endocervical canal, uterine perforation may 
occur. 
1. Uterine perforation: 
Perforation of the uterus may occur during sounding of the 
uterine cavity, during cervical dilatation or when visualization is 
impaired and the endoscope is forcibly advanced without panoramic 
vision. The instrument should be advanced gently with delicacy and 
always under direct vision. 
2. Infection: 
The appropriate selection, evaluation and screening of patients 
to undergo hysteroscopy will prevent possible infection. To avoid 
contamination during procedure sterile techniques should be 
maintained. 
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3. Bleeding: 
Uterine bleeding may occur, particularly after operative 
hysteroscopy. If extensive manipulations are performed, bleeding is a 
usual occurrence and usually subsides spontaneously. Minor spotting 
may occur after the usual intra-uterine examination, but generally 
subsides in a few hours. 
4. Medium related complications: 
These include anaphylactic reactions to dextran and massive 
intravasation of the CO2 gas with secondary hypercarbia and acidosis. 
Arrhythmias may also occur but are unlikely when appropriate 
instrumentation is used to deliver the CO2 gas. Inappropriate perfusion 
of dextrose 5% may produce water overload and electrolyte 
imbalance. This problem could be prevented easily by controlling and 
limiting the quantity of fluid and by expediting the procedure. 
TECHNIQUE OF HYSTEROSCOPY 
Under suitable anaesthesia, patient is put in lithotomy position. 
After catheterising the bladder, per-speculum and per-vaginal 
examination is done. Then hysteroscope is introduced into the cervical 
canal under vision. The cervical canal is examined and the 
hysteroscope is introduced into the uterus. The tubal ostia are 
visualized. The endometrial pattern is studied. 
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ANAESTHESIA 
Hysteroscopy requires cervical dilatation particularly when 
operating endoscopes are used. Therefore some type of anaesthesia is 
required. General anaesthesia, Paracervical block and Systemic 
analgesia are commonly used. 
ENDOMETRIAL STUDY BY HYSTEROSCOPE 
In describing different morphologies 5 well defined criteria are 
considered41: 
1)  The surface may be smooth (or) rough. 
2)  The height is constant in normal cases and decreases as 
nearing the isthmus and ostia. 
3)  The macroscopic details of the glandular opening. 
4)  The endometrial vessels. 
5) Tubal ostia — the normal ostia are smooth and straight with 
some parallel mucosal folds. 
Proliferative Endometrium41: 
• The surface is smooth and the colour is white or yellow. 
• Height of the endometrium is 2-5 mm. 
• Pores of endometrial glands are seen and are situated 
regularly. 
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• Superficial vascularisation forms are relatively poor and are 
seen as interrupted and punctate lines. 
• Tubal ostia are normal. 
Secretory Endometrium: 
• The surface is smooth or slightly rough. The colour varies 
from yellow to orange 
• Height of the endometrium is 5mm-7mm. 
• Superficial vessels have typical geometrical pattern 
mimicking a net. 
• Tubal ostia are normal. 
Natural Atrophy: 
• Surface is smooth and appears as white or yellow. 
• Height of the endometrium is less than 1mm. 
• Visible glandular openings are absent. 
• There is complete absence of superficial vessels though 
deeper vessels of stroma can be seen 
• The tubal ostia are either completely obliterated or seen as 
fibrous folds. 
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Hyperplasia (Simple), Adenomatous hyperplasia and Carcinoma 
In-Situ42: 
• The surface and colour are variable (white, yellow or even 
pink) 
• The endometrial height is quite uneven correlated with 
pseudopolypoid aspect and very thick. 
• Rich superficial vascularisation is observed with no specific 
pattern. The endoscopic examination easily provokes 
hemorrhage. 
• Some glandular orifices can be seen. They are no longer well 
delineated and the regular disposition has been lost. 
• Tubal ostia are normal. 
Cystic hyperplasia42: 
• Surface endometrial height and tubal ostia features are 
identical with hyperplasia. 
• Rich superficial vascularisation with the appearance of 
network is observed, but the pattern is unequal in size. 
• Trapped in the meshes of the "net" are several transparent 
cysts, which of often attain a diameter of several mm. Some 
are filled with a brown liquid suggestive of intra-cystic 
hemorrhage. 
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Polyps, Myomas and Carcinoma42: 
• Benign endometrial polyps are seen as smooth discrete, 
shiny & vascular. 
• Sub mucous fibroids appear smooth and paler than the rest 
of the endometrium. 
• Endometrial carcinoma appears as irregular lesion, 
vascularisation with surface ulceration and bleeding. 
Cervix: 
Cervical canal is seen as circular or oval with a smaller 
diameter antero posteriorly. 
It has a smooth mucous membrane with a whitish appearance 
different from the lining of the uterus. 
Endocervical arborvitae is seen with high magnification. 
ABNORMAL UTERINE BLEEDING  
Abnormal uterine bleeding is a common clinical problem with 
myriad causes. A solid knowledge of menstrual physiology and a 
thorough approach to differential diagnosis can evaluate and manage 
the problem with confidence. 
27 
Menstrual physiology  
A brief review of normal menstrual physiology is helpful in 
understanding abnormal uterine bleeding. The typical menstrual cycle 
has two phases: Proliferative and Secretory.  
The Proliferative phase is characterized by a predominance of 
estrogen over progesterone and a buildup of endometrium. The 
Secretory phase begins after ovulation triggers progesterone 
production. This phase is marked by a reaction to the combination of 
estrogen and progesterone and stabilization in the thickness of the 
endometrium.  
Menstrual bleeding occurs after secretion of estrogen and 
progesterone tapers off. Early during menses, thrombin plugs restrain 
blood loss, but later, vasoconstriction of the spiral arterioles is 
responsible for hemostasis. When ovulation does not take place, 
progesterone levels do not rise; therefore, typical cyclic withdrawal of 
estrogen and progesterone cannot occur.  
Normal menstrual cycles are characterized by a cycle length of 
28 days (+/- 7 days), a duration of flow of 4 days (+/- 2 days), and a 
blood loss of 40 mL (+/- 20 mL).  
28
Although trends exist for each type, there are no consistent 
relationships between abnormal bleeding patterns and their causes
43
.    
Terminology Used to Describe Abnormal Uterine Bleeding
43,60 
 
Menorrhagia  
Prolonged or excessive bleeding at regular intervals.  
Metrorrhagia  
A period of menstrual bleeding longer than 7 days or interval 
bleeding.  
Menometrorrhagia  
Prolonged or excessive bleeding at irregular intervals.  
Polymenorrhea  
Regular bleeding at intervals of less than 21 days.  
Oligomenorrhea  
Bleeding at intervals greater than every 37 days.  
Amenorrhea  
No uterine bleeding for at least 6 months.  
Intermenstrual  
Uterine bleeding between regular cycles.  
Post menopausal bleeding  
Uterine bleeding occurring more than 12 months after the last 
menstrual period of a menopausal women.  
29 
The first step in evaluation of AUB is to make certain that the 
bleeding is not from a gastrointestinal or urinary source. After this has 
been ruled out, the condition can be categorized into one of five 
distinct groups according to its cause
44, 45 
:  
(1)  Complications of pregnancy  
(2)  Reproductive tract abnormalities  
(3)  Systemic disease  
(4)  Iatrogenic factors, or  
(5)  Dysfunctional uterine bleeding.  
1. Complications related to pregnancy
46
:  
• Ectopic pregnancy  
• Gestational trophoblastic disease  
• Placental polyp  
• Spontaneous abortion (threatened, incomplete, missed)  
• Sub involution of the placental site  
• Placenta praevia.  
2. Abnormalities of the reproductive tract
46
:  
• Benign pelvic lesions  
• Adenomyosis  
• Endometriosis  
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• Polyps, cervical or endometrial  
• Submucosal fibroids  
• Infection  
• Malignancy  
• Trauma  
3. Systemic disease
46
:  
• Hepatic disease  
• Coagulation disorder  
• Hypothyroidism  
• Renal disease  
• Thrombocytopenia, von Willebrand’s disease  
• Hyperprolactinemia  
• Cushing’s disease  
• Polycystic ovarian disease  
• Leukemia  
• Stress  
• Adrenal dysfunction  
4. Iatrogenic factors
46
:  
• Anticoagulation therapy  
• Contraceptive use  
• Intrauterine device  
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• Levonorgestrol implant (Norplant System)  
• Medroxyprogesterone contraceptive injection (DepoProvera)  
• Oral contraceptives  
• Hormone replacement therapy  
• Psychotropic agents  
5. Dysfunctional Uterine Bleeding 
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Dysfunctional uterine bleeding (DUB), defined as abnormal 
uterine bleeding not caused by pelvic pathology, medications, 
systemic disease or pregnancy, is the most common cause of abnormal 
uterine bleeding but remains a diagnosis of exclusion.  
The cause of DUB is usually related to one of three hormonal-
imbalance conditions: Estrogen breakthrough bleeding, Estrogen 
withdrawal bleeding and Progesterone breakthrough bleeding.  
Estrogen breakthrough bleeding occurs when excess estrogen 
stimulates the endometrium to proliferate in an undifferentiated 
manner. With insufficient progesterone to provide structural support, 
portions of the endometrial lining slough at irregular intervals. The 
usual progesterone-guided vasoconstriction and platelet plugging do 
not take place, often resulting in profuse bleeding.  
Estrogen withdrawal bleeding results from a sudden decrease in 
estrogen levels, such as occurs following bilateral oophorectomy, 
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cessation of exogenous estrogen therapy or just before ovulation in the 
normal menstrual cycle. Estrogen withdrawal bleeding is usually self-
limited and tends not to recur if estrogen levels remain low.  
Progesterone breakthrough bleeding occurs when the 
progesterone-to-estrogen ratio is high, such as occurs with 
progesterone-only contraceptive methods. The endometrium becomes 
atrophic and ulcerated because of a lack of estrogen and is prone to 
frequent, irregular bleeding.  
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EVALUATION OF AUB 
HISTORY TAKING 
PHYSICAL EXAMINATION 
DIAGNOSTIC TESTING 
PREMENOPAUSAL WOMEN 
48 
 
If the reproductive-age woman is not pregnant and has a normal 
physical examination, AUB is usually dysfunctional in nature and can 
be managed with hormonal therapy.  
ANOVULATORY BLEEDING  
Anovulation is the most common cause of DUB in 
reproductive-age women and is especially common in adolescents. Up 
to 80 percent of menstrual cycles are anovulatory in the first year after 
menarche. Cycles become ovulatory an average of 20 months after 
menarche. If anovulatory bleeding is not heavy or prolonged, no 
treatment is necessary. If the adolescent is distressed by the 
irregularity of her menses or has been anovulatory for more than a 
year, oral contraceptive pills are the treatment of choice
47
.  
Some women still have anovulatory cycles after the 
hypothalamic-pituitary axis matures. Serum levels of thyroid-
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stimulating hormone and prolactin should be measured to exclude 
significant pathology. Weight loss, eating disorders, stress, chronic 
illness or excessive exercise may all cause hypothalamic anovulation.  
Another cause of anovulation is polycystic ovarian disease, 
which is usually associated with obesity, increased circulating 
androgens and insulin resistance. Excess androgens are converted to 
estrogen in peripheral tissues. This unopposed estrogen state increases 
the risk of endometrial hyperplasia and cancer. Some women with 
chronic anovulation do not fall into any of the above categories and 
are considered to have idiopathic chronic anovulation.  
All causes of anovulation represent a progesterone-deficient 
state. Treatment options include exogenous progesterone every three 
months to protect against endometrial cancer, oral contraceptives or, if 
pregnancy is desired, ovulation induction with clomiphene.  
OVULATORY DYSFUNCTIONAL BLEEDING 
Although less common than anovulatory bleeding, ovulatory 
DUB may also occur. DUB in women with ovulatory cycles occurs as 
regular, cyclic bleeding. Menorrhagia may signify a bleeding disorder 
or a structural lesion, such as uterine leiomyomas, adenomyosis or 
endometrial polyps. Up to 20 percent of adolescents who present with 
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menorrhagia have a bleeding disorder such as von Willebrand's 
disease. Liver disease with resultant coagulation abnormalities and 
chronic renal failure may also cause menorrhagia.  
Polymenorrhea is usually caused by an inadequate luteal phase 
or a short follicular phase. Oligomenorrhea in an ovulating woman is 
usually caused by a prolonged follicular phase. Intermenstrual 
bleeding may be caused by cervical disease or the presence of an 
intrauterine device. Midcycle spotting may result from the rapid 
decline in estrogen levels before ovulation
47
.  
An endometrial biopsy should be considered early in the 
evaluative process of women who have a history of prolonged 
exposure to unopposed estrogen, who do not respond to initial 
management strategies or who are over age 35.  
CHARACTERISTICS OF OVULATORY AND 
ANOVULATORY CYCLES 
47
  
Ovulatory cycles  
1.  Regular cycle length  
2.  Presence of premenstrual symptoms  
3.  Dysmenorrhea  
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4.  Breast tenderness  
5.  Change in cervical mucus  
6.  Mittleschmertz  
7.  Biphasic temperature curve  
Anovulatory cycles  
1.  Unpredictable cycle length  
2.  Unpredictable bleeding pattern  
3.  Frequent spotting  
4.  Infrequent heavy bleeding  
5.  Monophasic temperature curve  
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PERIMENOPAUSAL WOMEN 
As women approach menopause, cycles shorten and often 
become intermittently anovulatory. These changes are the result of a 
decline in the number of ovarian follicles and in the estradiol level. As 
follicles decrease in number, the level of follicle-stimulating hormone 
needed to stimulate ovulation increases.  
EXCLUDING ENDOMETRIAL CARCINOMA
48
 
All perimenopausal women with persistent AUB should be 
evaluated for the presence of endometrial hyperplasia or carcinoma. 
Endometrial biopsy is the most widely used and best studied method 
of excluding endometrial carcinoma in this age group. In women with 
normal findings on biopsy, treatment usually consists of monthly 
progesterone withdrawal or low-dose oral contraceptives. If bleeding 
continues despite hormonal therapy, further investigation is warranted. 
HYSTEROSCOPY 
Hysteroscopy with biopsy allows visualization of the 
endometrial cavity and is regarded as the "gold standard" for 
endometrial assessment. Diagnostic hysteroscopy can be performed in 
an office setting and requires no anesthesia or sedation. Operative 
hysteroscopy utilizes a rigid scope with a fluid distending medium and 
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is useful for diagnosis and treatment. Before hysteroscopy was 
available, curettage was the primary method of evaluating AUB. 
Curettage, however, renders endometrial sampling blind and 
incomplete, so the diagnostic accuracy of curettage is less than that of 
hysteroscopy.  
POSTMENOPAUSAL WOMEN  
The most serious concern in postmenopausal women with AUB 
is endometrial carcinoma. Of all postmenopausal women with 
bleeding, 5 to 10 percent are found to have endometrial carcinoma. 
Other potential causes of bleeding are cervical cancer, cervicitis, 
atrophic vaginitis, endometrial atrophy, submucous fibroids, 
endometrial hyperplasia and endometrial polyps
48
.  
HORMONE REPLACEMENT THERAPY  
Women receiving hormone replacement therapy often presents 
with abnormal bleeding and, of these, 30 percent have uterine 
pathology. Other causes include cervical lesions, vaginal pathology or 
the hormone therapy itself. Women receiving sequential hormone 
replacement therapy may experience midcycle breakthrough bleed 
resulting from missed pills, medication interactions or malabsorption. 
If unscheduled bleeding occurs in two or more cycles, further 
evaluation is indicated
48
.  
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ENDOVAGINAL SONOGRAPHY 
Endovaginal sonography is performed employing an 
endovaginal transducer probe. Usually a probe with acoustic 
frequency of 5 MHz is employed. Due to improved resolution of the 
high frequency transducer and the proximity of the probe tip to the 
organ imaged, endovaginal sonography has been found to provide 
better visualization of the pelvis and perfect clarity of hollow organs 
as well as adjacent structures.  
MERITS 
It gives a magnified but clear picture of the individual pelvic 
organs and hence the morphology can be studied in detail.  
Vaginal sonography is performed with the empty  urinary 
bladder. Hence the discomfort and time required for a full urinary 
bladder could be totally avoided. 
The possibility exists to perform endovaginal sonographic 
inspection immediately  after the bimanual pelvic examination and 
even simultaneously. 
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LIMITATIONS 
The examination is impossible with an intact hymen or with a 
very narrow vagina. Hence trans abdominal approach should be 
preferred for pediatric and adolescent subjects same is true for 
subjects with congenital anomalies of the genital tract where vaginal 
introduction of the probe is difficult. The penetration is only 10 cms 
hence associated pedunculated myoma or ovarian masses which are 
bigger in size, may not be delineated properly.  
METHODOLOGY 
The best position for the patient for endovaginal sonography is 
dorsal position with the legs flexed as it is for bimanual pelvic 
examination or lithotomy position.  A condom or glove is slipped over 
the probe before examination for reasons of hygiene and readiness for 
the next patient. A small amount of coupling gel is applied to the inner 
surface of the tip of the probe before applying the condom or glove 
and this is to ensure contact and to eliminate the air pockets that could 
intervene. The tip of the scanner probe is placed adjacent to the 
anterior fornix (or to the posterior with retroverted uterus) for an 
evaluation of the uterus and cervix. 
With endovaginal scanning the uterus can be imaged in 3 
different scanning planes.  
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1. Sagittal or long axis views 
2. Semi-coronal views 
3. Semi-axial views 
First the endometrium is imaged in its long axis by gently 
angled  sagittal  scans through the uterus with the probe head in the 
region of uterine  cervix. Next the endometrium is imaged in its short 
axis in semi-coronal or semi-axial planes by turning the probe 
approximately to 90 Deg. 
ENDOMETRIAL STUDY BY ENDOVAGINAL SONOGRAPHY 
Due to the increased proximity of the endovaginal probe to the 
uterus and hence to the endometrium, endovaginal approach gives an 
excellent opportunity to study the endometrium very closely. A very 
clear and magnified view of the endometrium provided by the high 
frequency transducer permits precise evaluation of endocrine response 
of the endometrium and help to diagnose endometrial pathology. 
   Normally the uterine cavity is empty and hence it is 
represented by the  two layers of endometrium in apposition and the 
sonographic  appearance is that of a clear echogenic line. 
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MENSTRUAL ENDOMETRIUM 
The endometrial cavity is filled with small echo-free spaces 
suggesting the presence of blood cots. The endometrial lining will be 
thin and relatively less echoic. 
PROLIFERATIVE ENDOMETRIUM 
The growth of the endometrial glands and stromal oedema is 
identified in the form of gradually increasing thickness of the 
endometrium. During the mid-proliferative phase the hypoechoic area 
surrounded by echogenic line widens due to increasing stromal 
oedema. In the impending pre-ovulatory period, the stromal  oedema 
is maximal. This results in significant widening of echofree zone and 
intense echogenicity of the endometrial lining. The endometrial 
thickness increases gradually from 2-3 mm in early proliferative phase 
to upto 8-10 mm in late proliferative phase. 
SECRETORY ENDOMETRIUM 
During the luteal phase, the secretions of the glands are 
discharged into the lumen of the endometrial cavity. This is 
recognized at scan in the form of an echo-free endometrial cavity 
being lined by thick and relatively echogenic endometrium. During 
mid-secretory phase there is regression of endometrial glandular 
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elements and prominence of stromal cells. This leads to increased 
thickness of the endometrium which becomes more echogenic. During 
the late secretory phase there is prominence of stromal cells which 
gives a strong  echogenic fluffy appearance to the endometrium and 
also adds to the thickness of the endometrium. The endometrial 
thickness can increase to 10-14 mm during the secretory phase. 
HYPERPLASTIC ENDOMETRIUM 
Hyperplastic endometrium has characteristic unmistakable 
picture by sonography. The intensely echogenic and thick 
endometrium surrounded by echo free periphery is quite diagnostic. 
The endometrium thickens and becomes pseudopolypoid in 
configuration. In these patients, thickening of the endometrium 
beyond what is expected for women of comparable age is detected. In 
perimenopausal women endometrial thickness greater than 14 mm 
should be considered for further evaluation, whereas in the post-
menopausal women endometrial thickness more than 5 mm should be 
considered abnormal. 
ATROPHIC ENDOMETRIUM 
The hypo oestrogenic  endometrial status is clearly 
demonstrated by a thin echogenic line and a relatively smaller uterine 
size. This picture is usually encountered in post menopausal subject. 
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DILATATION AND CURETTAGE 
This is the commonest gynecological operation. It can be 
diagnostic, to study the pattern of endometrium in menstrual problems 
and can be therapeutic, if there is continuous uterine bleeding of 
dysfunctional type. (Vow et al 2007). It detects benign pathology in 
about 80% of patients with menstrual dysfunction. It is the most likely 
procedure to detect the problem when pathology affects the 
endometrium globally. It is most frequently done as an adjuvant 
procedure to hysteroscopy (Epstein et al 2001)  
TIMING OF ENDOMETRIAL BIOPSY 
In order to obtain the maximum information from an 
endometrial biopsy, it is important for the clinician to provide accurate 
and complete clinical details and secondly for the sample to be taken 
at the optimum time and from the appropriate site in the uterus. 
Request form should provide the date of LMP, use of any steroid 
hormones, mode of contraception, use of any drugs which are known 
to interfere with the normal secretion of trophic hormones, menstrual 
history, and details of any endocrinological disease. 
Endometrial biopsy should be taken from anterior or posterior 
wall in the uterine body, where cyclical changes are likely to be more. 
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Uterine isthmus fails to undergo cyclical changes and common error 
of the inexperienced surgeon is to sample, the endometrium too low 
down in the cavity. 
Basal endometrium fails to show normal cyclical changes and 
therefore the immediately post menstrual biopsy may fail to provide 
useful information. In patient’s with IUD, removal of tissue from the 
contact site may give false impression of infection, irregular ripening, 
scarring. Pathological process may be identified at any time for 
example hyperplasia and neoplasms. Best time for observing cyclical 
changes in between 7th and 11th post ovulatory days. 
Disadvantages of D &C 
• Only 70-80% of the endometrium can be curetted 
• Polyps and submucous fibroids are frequently undetected by 
curettage alone. 
ENDOMETRIAL ASPIRATION CYTOLOGY 
  Recently thin plastic cell samplers have been developed (Skarr 
Land 1986) which provide a histological sample without the need for 
dilatation or anaesthesia. Several makes are available, including the 
Gravlee jet Washer (Gravlee 1969), the Issac’s sampler (Issac 
&wilhoite1974) and the Pipelle. The vabra aspirator usually provides 
46
a greater amount of tissue for analysis and is probably no less efficient 
in diagnosing endometrial malignancy than D &C (Grimes 198) 
TRANSVAGINAL SONOHYSTEROGRAPHY 
Randolph in 1986 first described the use of intrauterine saline 
infusion during preoperative transabdominal USG evaluation to detect 
intrauterine abnormalities. Diechert et al in 1988, first demonstrated 
that transvaginal  sonohysterography was useful in  diagnosis of 
endometrial lesions. This contrast transvaginal scanning with fluid in 
endometrial cavity or air may improve the reliability of transvaginal 
ultrasonography. It can evaluate the symmetry of endometrial wall 
thickness and delineate any intraluminal masses. The combination of 
endometrial biopsy and transvaginal sonohysterography positively 
correlated with surgical findings more than 95% and 96% 
respectively. (Dubinsky L Ahuy- Gazzehy. Stroehlein K. done in 
Mar-98). No patients with endometrial hyperplasia or cancer were 
misdiagnosed. 
47
Treatment options for Dysfunctional Uterine Bleeding
46 
 
Premenopausal:  
• Oral contraceptives: Low dose (35mcg) monophasic or 
triphasic oral contraceptives can regulate cycles while 
providing contraception.  
• Medroxyprogesterone: (10mg/day for 10 days) If 
contraception is not an issue, it can be used to regulate 
cycles. In a woman who has amenorrhea or oligomenorrhea, 
medroxyprogesterone every 3 months can protect against 
endometrial hyperplasia. Intra Uterine device containing 
levonorgestrol reduces blood loss by 95%. 
• Clomiphene: (50-150mg/day on days 5 to 9) can induce 
ovulation in a woman who desires pregnancy.  
Perimenopausal:  
• Medroxyprogesterone: (10 mg per day for 10 days) May 
use monthly to regulate bleeding patterns.  
• Oral contraceptives: (20-μg) Can continue oral 
contraceptives until a woman has finished menopause and 
then change to HRT. (May be a relative contraindication in 
women >35 years of age and who smoke)  
Postmenopausal (receiving HRT):  
• Cyclic HRT: Consider increasing the progesterone dose if 
early withdrawal bleeding occurs. Increase the estrogen 
dose if intermenstrual bleeding is present.  
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• Continuous combined HRT: May increase the estrogen 
dose for 1 to 3 months to stabilize the endometrium. May 
also try increasing the progesterone dose. If bleeding 
continues, consider changing regimen to cyclic HRT or 
using a different type of estrogen. 
  
CONSERVATIVE  SURGERIES 
1. Endometrial Ablation Techniques   
A. Non Hysteroscopic  Endometrial Ablation 
a. Thermal Balloon 
b. Cryotherapy   
c. Direct instillation of heated saline  
d. Microwave endometrial ablation 
e. Radio frequency  electromagnetic energy (Corson etal, 
O.Connor, Magos) 
B. Using Hysteroscopic  guidance  
a. Nd. yag laser 
b. Trans cervical resection of Endometrium   
c. Roller ball coagulation  
d. Radio frequency induced thermal endometrial ablation. 
Hystrectomy is the last resort when  all modalities of treatment fail.  
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MATERIALS AND METHODS 
SOURCE OF DATA 
The present study “A comparative study of hysteroscopy and 
transvaginal ultra sonography in the evaluation of AUB in 
reproductive age group” is a prospective study which was undertaken 
at the Institute of obstetrics and gynecology,  Chennai. 
   Fifty patients with clinical diagnosis of AUB were selected at 
random from the Gynecology Out Patient Department of the Institute 
of obstetrics and gynecology Chennai. The age group of the selected 
patients ranged from 20 to 40 years. Almost all the patients belonged 
to Socioeconomic classes IV or V.  
All the patients underwent TVS, Hysteroscopy followed by 
curettage and removal of abnormal lesions like Polyps and Submucous 
fibroid and the material was sent for histopathalogical analysis. The 
period of study was from Aug-09 to Aug-10.  
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METHOD OF COLLECTION OF DATA  
Inclusion Criteria 
i.    Age  
    Patients with age group in the range of 20 to 40 years with     
  AUB were selected. 
ii. Parity 
 The  study included only parous women with abnormal 
uterine bleeding. 
iii.   General condition of the patient 
        Patients who do not have any other medical or surgical 
complications and who do not require any emergency 
management were selected for this study. 
Exclusion Criteria 
i. Patients with severe anemia due to menorrhagia were 
excluded from the study since they required immediate 
intensive care. 
ii. Patients with profuse bleeding were also excluded from the 
study since they required emergency therapeutic curettage. 
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iii. Patients with medical complications like uncontrolled 
diabetes mellitus or hypertension were also excluded from 
the study to preclude any anesthetic or surgical risks during 
hysteroscopy. 
iv. Nulliparous patients with dysfunctional uterine bleeding 
were also excluded from the study. 
 A thorough history  was  taken and recorded from all  the  
patients  thus    selected. 
These patients were then subjected to a general and bimanual 
pelvic examination. The following baseline investigations were 
performed on all patients. 
- Urine examination for albumin, sugar and deposits. 
- Blood Hemoglobin estimation (in gm%), grouping, 
typing, BT, CT 
- Electrocardiography for patients above the age of 35 
years and x-ray for anesthetic fitness 
Anesthetic assessment was made on the day of admission. The 
patients were advised to have a light dinner before 10.00 pm on the 
night prior to hysteroscopy. The patients were prepared as for any 
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other surgical procedure. The next day, prior to hysteroscopy an 
endovaginal sonography was performed on all these patients. 
ENDOVAGINAL SONOGRAPHY 
  The patients after emptying her bladder were put in dorsal 
position. The probe covered by a condom was inserted into the 
introitus after gentle separation of labia majora by the examiner’s 
fingers and downward pressure on the posterior commissure of the 
labia minora. 
The following points were noted during endovaginal 
sonography.  
I. Thickness of the endometrium  
II. Stromal oedema-represented by clear echo free space 
surrounding the periphery of the echogenic endometrial line  
III. Any other uterine or adnexal pathology which could not be 
detected clinically. 
  After endovaginal sonography the patient was wheeled to the 
theater where hysteroscopy and dilatation and curettage were 
performed. 
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 FIG 3: TVS PICTURE OF ENDOMETRIAL POLYP
FIG 4: TVS PICTURE OF SUBMUCOUS FIBROID
HYSTEROSCOPY 
The patient was examined and re-assessed by the anaesthetist in 
the theater. After a routine examination which included vital data such 
as temperature, pulse, Blood pressure and cardio vascular and 
respiratory system examination, patient was put in lithotomy position. 
The part to be examined was cleaned with antiseptic solution. Draping 
was done. 
 In this study the hysteroscopy was performed under intra 
venous ketamine anesthesia. 
ANESTHESIA 
         Route 
         Intravenous 
         Drugs Used   
         i.    Ketamine hydrochloride 2 mg/kg 
        ii.    Diazepam 10 mg 
       iii.   Atropine 0.6 mg 
EFFECTIVE PERIOD 
        15.20 minutes 
54
 FIG: 5 HYSTEROSCOPIC VIEW OF NORMAL UTERINE CAVITY WITH TUBAL OSTIA  
FIG 6 : HYSTEROSCOPIC VIEW OF SUBMUCOUS FIBROID 
HYSTEROSCOPE – KARL STORZ (GERMANY) 
Telescope used was 4 mm, 30 Deg, fore-lens with a 5mm 
sheath. Illumination provided by fibre optic cable.   
INSTRUMENTS 
1. Speculum,  
2. Vulsellum,  
3. sponge holding forceps,   
4. Distending medium- normal saline with a drip set  
    and insufflation cuff.  
5. D&C set with Hegar’s dilators. 
Under anaesthesia after catheterising the bladder a bimanual 
pelvic examination was done. After introducing sim’s speculum, the 
anterior lip of the cervix was caught with vulsellum. After measuring 
the length of the uterine cavity , the internal os was dilated upto 7 
Hegar’s dilator which was sufficient in most of the patients. A 
hysteroscope was introduced into the cervical canal under vision. The 
inflatable cuff surrounding the distending medium was inflated to 100 
mm of Hg and maintained between 80-100 mm of Hg. The drip set 
attached to the distending medium was attached to the inflow channel 
of the hysteroscope. The uterine cavity was attached to the inflow 
channel of the hysteroscope. The uterine cavity was examined and the 
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FIG 7 : HYSTEROSCOPIC PICTURES  OF ENDOMETRIAL POLYPS 
 following points were noted. The nature of surface and colour of the 
endometrium were noted. The glandular opening and vascular pattern 
were studied. The uterine cavity was examined for presence of  any 
other abnormalities. The tubal ostia were visualized. Any blood clots 
present in the cavity will be rinsed off by the fluid used as distending 
medium. The time taken for the procedure and amount of fluid used 
were noted carefully at the end of the procedure. 
DILATATION AND CURETTAGE 
 Under same anesthesia endometrial curettage was done and 
curettings were sent for histopathogical examination. The lesions like 
polyps and submucous fibroids were removed at the same sitting and 
specimen was sent for HPE.  
 After the procedures were over, the patients were shifted to 
post- operative ward where they were kept under observation for 24 
hrs. 
COMPLICATIONS 
        The following complications were noted following hysteroscopy.  
I. 3 out of 50 patients had bleeding from the cervical lip 
(trauma produced by vulsellum) which required tight 
packing for 6 hours and careful monitoring for vaginal 
bleeding in the post operative period. 
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FIG 8 : SLIDE SHOWING PROLIFERATIVE PHASE – ENDOMETRIUM 
FIG 9 : SLIDE SHOWING SECRETORY PHASE - ENDOMETRIUM 
 II 8 patients had vomiting mainly due to anesthetic drugs  
 which subsided after symptomatic treatment 
III There was no infective morbidity in the present study. 
Similarly fluid overload and electrolyte disturbance were 
also not encountered in the present study. The complications 
following endovaginal sonography were nil.  
 
DURATION OF HOSPITAL STAY 
All the patients had minimal hospital stay only for three days.  
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 FIG 10 : SECRETORY PHASE ‐ ENDOMETRIUM
FIG 11 : HYPERPLASTIC ENDOMETRIUM
RESULTS AND ANALYSIS 
 
This study conducted at the Institute of Obstetrics and 
Gynecology, Chennai during the period of 2009-10 compares the 
efficacy of Hysteroscopy and Transvaginal ultra Sonography (TVS) in 
the evaluation of AUB in reproductive age group. The Hysteroscopic 
and Sonographic findings are correlated with histopathological 
diagnosis  of endometrium obtained by curettage.  
Total number of patients selected: 50  
 Table 1: Age Group  
AGE GROUP      Number % 
20-25 16 32.0 
26-30 20 40.0 
31-35 9 18.0 
36-40 5 10.0 
Total 50 100.0
 
Among the reproductive age group, patients in the age group of 
26 – 30 constitute 40%. 
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AGE  GROUP  IN AUB
20‐25 Y rs  
(32.0% )
26‐30 Y rs (40.0% )
31‐35 Y rs (18.0% )
36‐40 Y rs  
(10.0% )
 
 
Table 2: Parity and AUB  
PARITY Nu
mber %
1-2 24 
4
8 
3-4 21 
4
2 
>4 5 
1
0 
Total 50 
1
00.0 
 
Patients having 1 – 2 children constitute the majority - 48% of 
cases ; whereas multiparous women having more than 4 children 
constitute only 10%.  
Table 3: Prominent pattern of bleeding  
PATTERN  OF BLEEDING Number % 
Polymenorrhea  16 32 
Menorrhagia 21 42 
Poly Menorrhagia 8 16 
Metorrhagia 5 10 
Total 50 100 
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Commonest pattern of bleeding is menorrhagia accounting for 
42% of cases.  
PAR ITY  IN AUB
>4 (8.2% )
3‐4 (42.9% )
1‐2 (49.0% )
PATTE RN OF  BL E E DING  IN AUB
 P olymen(32% )
Men (42% )
P olymenr (16% )
Met (10% )
 
  
Table 4: Duration of illness  
DURATION OF ILLNESS Number % 
<3 20 40 
3-6 20 40 
6—1 9 18 
>1 1 2 
  50 100 
80% of patients sought medical advice within 6 months of 
illness; whereas only 2% of patients sought the medical advice after 1 
year of illness.  
Table 5: Evaluation by Histo Pathological Examination (HPE) 
HPE Number % 
Proliferative  21 42 
Secretory 16 32 
Hyperplasia (simple) 4 8 
Endocervical Polyp 7 14 
Submucous Fibroid 2 4 
Total 50 100.0
By Histopathology 37 patients (74%) had normal endometrium. 
Histopathology diagnosed 4 cases of hyperplasia and 7 cases of 
endometrial polyp, 2 cases of Submucous fibroid.   
60
Duration  of S ymptoms
40 40
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E valuation  by HPE
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32
8
14
4
0
5
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 Table 6: Evaluation by Hysteroscopy  
HYSTEROSCOPY Number %
Normal study 
3
9 
7
8 
Hyperplasia (simple) 2 4
Endocervical Polyp 7 
1
4 
Submucous Fibroid 2 4
Total 
5
0 
1
00.0 
Abnormal findings were seen in 11 patients (22%), while in the 
remaining 39 patients (78%), no abnormality was detected.  
Table: 7 Evaluation by Transvaginal ultrasonography (TVS) 
TVS Number %
Proliferative  
2
7 
5
4 
Secretory 
1
5 
3
0 
Hyperplasia (simple) 4 8
Endocervical Polyp 3 6
Submucous Fibroid 1 2
61
Total 
5
0 
1
00.0 
In the present study there were no malignancies detected. 4 out 
of 50 patients had simple hyperplasia, whereas in 37 out of 50 
patients, endometrium was normal.  
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Comparison of Endometrial study by HPE, Hysteroscopy , TVS 
 
VALIDITY OF HYSTEROSCOPY 
 Disease Actually  
Hysteroscopy   Present Absent  
Positive 10 (a) 1 (b) 11(a+b) 
Negative 3 (c) 36 (d) 39 (c+d) 
 13 (a+c) 37 (b+d) 50 
 
Sensitivity (a/(a+c))x100 76.90 
Specificity (d/(d+b))x100 97.30 
Positive Predictive Value (a/(a+b))*100 90.90 
Negative Predictive Value (d/(d+c)*100 92.30 
False Positive rate (b/(b+d))*100 2.70 
False negative rate (c/(a+c))*100 23.07 
Concordance (Accuracy) ((a+d)/(a+b+c+d))*100 92 
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VALIDITY OF TVS 
 Disease Actually  
 TVS Present Absent   
Positive 7 (a) 1(b) 8 (a+b) 
Negative 5 (c) 37 (d) 42 (c+d) 
  12 (a+c) 38 (b+d) 50 
 
Sensitivity (a/(a+c))x100 58.3 
Specificity (d/(d+b))x100 97.4 
Positive Predictive Value (a/(a+b))*100 87.5 
Negative Predictive Value (d/(d+c)*100 88.1 
False positive rate (b/(b+d))*100 2.63 
False negative rate (c/(a+c))*100 41.66 
Concordance (Accuracy) ((a+d)/(a+b+c+d))*100 88% 
 
COMPARISON OF VALIDITIES 
  Hysteroscopy TVS 
Sensitivity 76.9 58.3 
Specificity 97.3 97.4 
Positive Predictive Value 90.9 87.5 
Negative Predictive Value 92.3 88.1 
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DISCUSSION 
 
In the present study “A comparative study of hysteroscopy and 
transvaginal ultra sonography in the evaluation of AUB in 
reproductive age group”  diagnostic hysteroscopy and TVS were 
performed followed by Curettage or removal of intrauterine pathology 
like Submucous myoma, Polyps in 50 consecutive cases of AUB and 
its correlation with histopathological findings were sought. 
PATIENT CHARACTERISTICS 
 Age group: The age group in this study was between 22 to 40 
years and the maximum incidence was between was between 26 to 30 
years.  Panda49 found that maximum age incidence was between 35-
45yrs in range between 25-70yrs. In Gianninoto’s22 series, age range 
was 38-80yrs and commonest incidence was between 30-45yrs. 
Trotsenburg50 reported maximum age incidence between 41-50yrs. 
Mojgan Barati et al , Sara  Mashihi26 et al reported maximum 
incidence of AUB in more than 40 years age group.  
Nabil et al, Peter Slamka59 et al reported maximum incidence 
in the age group of 30 to 35 years.  
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Kekelci51 et al reported 34.3% of incidence in 40 to 50 years 
age group.   
PROMINENT PATTERN OF BLEEDING 
The commonest presenting complaint in this series was 
menorrhagia 42%, followed by Polymenorrhea 32% and 
polymenorrhagia 16%. Panda’s49 series had 60% cases of 
menorrhagia followed by Polymenorrhagia and Metrorrhagia.  
Tahir MM et al, Bigrigg et al27 Menorrhagia 40.75%, PMB 30.75% 
Kekelci et al51  Menorrhagia 21%, PMB 13.3%, 
Menometrorrhagia 65.7% 
Ameera Takreen et al (2001) Menorrhagia 53.3%, 
Polymenorrhagia 6.6%, 
Polymenorrhea 40% 
 
ABNORMAL FINDINGS 
In this study abnormal findings in hysteroscopy were found in 
11 patients (22%), while 39 patients (78%), had no abnormality 
detected.  
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Table No 8: Normal and Abnormal findings at Hysteroscopy in 
various series. 
Sl. No. Author (Year) No. of 
Cases 
Normal 
(%) 
Abnormal 
(%) 
1 Wamsteker (1984) 
52
 199 41.5 58.5 
2 Gimpelson & 
Rappold (1988) 
53
 
276 60 40 
3 Loffer (1989) 
54
 91 48.66 51.44 
4 Sheth (1990) 
55
 51 44 56 
5 Parasnis (1992) 
56
 96 73.95 26.05 
6 Neumann (1994) 
57
 85 55.2 44.8 
7 Panda (1999) 
40
 66 46.6 53.4 
8 Trotsenburg (2000) 
50
 819 66 34 
9 Garuti (2001) 
18
 1500 61.8 38.2 
10 Gianninoto (2003) 
22
 512 25 75 
11 de Wit AC (2003) 
23
 1045 54.2 45.8 
12 Present Series  50 78 22 
Of the 11 patients with abnormal findings on hysteroscopy, 
commonest lesion seen was endometrial polyp (7 cases – 14%), 
followed equally by endometrial hyperplasia and submucous fibroids 
(2 cases each – 4% each) 
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Panda49 found endometrial hyperplasia in 28.3%, Wamsteker52 
found endometrial polyp in 19%, endometrial hyperplasia in 12.2% 
and submucous myoma in 7.8%, Trotsenburg50 observed myomas 
and polyps in 14% and deLewit23 reported myomas in 21% and 
polyps in 14.4%. 
Hysteroscopy diagnosed endometrial hyperplasia, polyps and 
myomas with a specificity of 97.3%. Sheth55 reported 81.8 % 
accuracy in diagnosis of polyps and myomas, while Garuti18 reported 
95.4% specificity in diagnosis of polyps. 
In 39 cases of normal Hysteroscopic study, 3 abnormal findings 
were detected on histopathology. They were 2 cases of simple 
hyperplasia and 1 endometrial polyp.  
1 Case of polyp diagnosed by hysteroscopy was later diagnosed 
to be proliferative endometrium. The detection on intra uterine 
pathology like endometrium polyp had an accuracy of 57.1%, 
submucous fibroid had an accuracy of 100% with hysteroscopy.  Even 
though hysteroscopy diagnosed 2 cases as hyperplasia, histopathology 
showed them to be endometrial polyps.  
The accuracy of hysteroscopy in this study was 92%.  
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 Table No 9: Comparison of Accuracy of Hysteroscopy findings in % 
 
Author  Accuracy  Misinterpretation  
Baggish (1979) 
15
 87.5  12.5  
Barbot (1980) 
58
 84  16  
Sheth (1990) 
55
 82  18  
Parasnis (1992) 
56
 92  8  
Panda (1999) 
49
 92.69  7.31  
Present Series  92  8  
 
Test Used: F Test P=1>0.05 NS 
A Statistical analysis of the accuracy  obtained by various 
authors and of the present study shows that there is no significant 
difference between values. 
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Table No 10: Comparison of Validity factors  Hysteroscopy ( in%) 
 
Test Used: F Test P=0.3688>0.05 NS 
There is no significant difference between sensitivity & 
specificity obtained in the study and that obtained by various other 
authors.  
Author Sensitivity 
Specifi
city PPV NPV Accuracy 
Nabil el Tabbakh 
(All age groups)59 75.7 94.6 84.4 91.6 89.8 
Nabil el Tabbakh59 
(Premenopausal 
age) 
67.4 94.3 80.6 89.2 87.3 
Mojgan Barati26 97.8 99 94 99  
Kekelci, Kaya E, 
Alan M 51 100 80.5 88.9 100  
Epstein et al 25 100 84 86.6 94  
Garuti et al 31 96.5 93.6 92.6   
Jacob et al (2001) 97 82.5    
Paschapoulos 
(2001)  92 95    
Deuholm (2001) 84 88    
Bonnamy (2002)  78 97    
Present series 76.9 97.3 90.9 92.3 92 
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TRANS VAGINAL SONOGRAPHY 
In this study abnormal findings on TVS were found in 8 
patients (16%), while in the remaining 42 patients (84%) no 
abnormality was detected.  
Of the 8 patients with abnormal findings on TVS, commonest 
seen was endometrial hyperplasia – 4 cases (8%) followed by 
endometrial polyp–3 cases (6%) and submucous fibroid – 1 case (2%).  
TVS diagnosed hyperplasia, endometrial polyp and myomas 
with a specificity of 97.4%. TVS made a false positive diagnosis of 
hyperplasia in 1 case, missed the diagnosis of endometrial polyp in 5 
cases and submucous fibroid in one case.  
It had misdiagnosed 3 cases of polyps, as hyperplasia in 1 case, 
1 as normal proliferative endometrium and the other as secretory and 
misdiagnosed 1 submucous fibroid as polyp.   
If saline infusion sonography had been done in addition to TVS, 
the diagnostic accuracy would have increased since it will delineate 
polyps and fibroids well.  
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Table No:11 Comparison of Validity factors - TVS ( in%) 
Author Sensiti
vity Specificity PPV NPV Accuracy 
Nabil el Tabbakh 
(All age groups)59 77 94.6 84.4 91.6 89.8 
Nabil el Tabbakh 
(Premenopausal 
age) 59 
67.4 94.3 80.6 89.2 87.3 
Mojgan Barati26 96.8 97 94 78.9  
Epstein et al25 49 86 84 88  
Garuti et al (Cut off 
4 mm)31 95 54.8 63.7   
Garuti et al (Cut off 
8 mm)31 83.8 81.3 79.4   
Present series 58.3 97.4 87.5 88.1 88 
Test Used: F Test P=0.9962>0.05 NS 
A comparison of sensitivity and specificity of TVS obtained in 
the present study with those obtained by other authors show no 
significant difference between the obtained values.  
The complications among patients noted post operatively.  
• Vomiting : 10 cases 
• Bleeding :   2 cases (due to cervical lip injury by Vulsellum) 
• Infection : Nil 
• Perforation : Nil  
There was no procedure related mortality in this study.  
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SUMMARY 
1. 50 patients presented with AUB underwent TVS, hysteroscopy 
followed by curettage and removal of pathological lesion 
2. Curetted endometrium sent for HPE  
3. Age group in this study 20 – 40 years. Maximum incidence was 
between 26 – 30 years (40%)  
4. The commonest presenting complaint was menorrhagia 42% 
followed by polymenorrhea 32% and polymenorrhagia 16% and 
metrorrhagia  10%.  
5. 80% of patients had symptoms for less than 6 months and only 
2% had symptoms for more than one year.  
6. Hysteroscopy  reported 22% as abnormal as while in 78% no 
abnormality was detected.  
7. The commonest lesion detected by hysteroscopy was endometrial 
polyp – 14% followed equally by hyperplasia and submucous 
fibroid (4% each). 
8. The sensitivity, specificity, PPV,NPV for hysteroscopy was 
76.9%, 97.3%, 90.9% and 92.3% respectively.  
9. TVS reported 16% as abnormal findings and in the  remaining  
84% no abnormality was detected.  
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10. Most common abnormal lesion detected by TVS was endometrial 
hyperplasia 8% followed by endometrial polyp 6% and 
submucous fibroid 2%. 
11. The sensitivity, specificity, PPV,NPV for TVS was 58.3%, 
97.4%, 87.5% and 88% respectively.  
12. Accuracy of hysteroscopy in this study was 92% and that of TVS 
was 88%.  
13. Concordance of hysteroscopy along with curettage was 78% and 
that of TVS with curettage was 54%  
14. No major post operative complications were noted in this study. 
15. No procedure related mortality or infectious morbidity was noted 
in this study.   
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CONCLUSION 
 
This study confirms that hysteroscopy is superior to transvaginal 
sonography in evaluating abnormal uterine bleeding.  
Hysteroscopy is a safe reliable and quick procedure in the 
diagnosis of cases with abnormal uterine bleeding with high 
sensitivity, specificity, positive predictive value, negative predictive 
value.   
Transvaginal sonography can be used as the first line diagnostic 
technique but hysteroscopy followed by histopathological examination 
should be considered as “Gold standard” for evaluation of abnormal 
uterine bleeding.  
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ANNEXURE 1 
 
PROFORMA 
NAME :      AGE : 
IP NO :     EDUCATION :   
                  OCCUPATION : 
D.O.A :                                       S. E. STATUS : 
D.O.OP :                                               ADDRESS : 
D.O.D : 
COMPLAINTS: 
AM 
ML 
MH- PRESENT 
PAST CONTRACEPTION : 
NO OF CHILDREN :                                        L.C.B : 
STERILIZATION DONE/NOT L.M.P : 
PAST HISTORY: 
H/O D&C 
TUBAL LIGATION/ IUCD 
H/O DIABETES 
H/O HORMONE THERAPY 
H/O BLEEDING DISORDERS 
H/O ANTICOAGULANT DRUGS 
H/O TUBERCULOSIS 
H/O HYPO OR HYPERTHYROIDISM 
OBSTETRIC HISTORY: 
FAMILY HISTORY: H/O BLEEDING DISORDERS 
DRUG HISTORY: HORMONES FOR DUB 
GENERAL EXAMINATION: 
VITAL DATA                  PR:                 BP: 
ABDOMINAL EXAMINATION: 
BIMANUAL PELVIC EXAMINATION: 
UTERUS-SIZE                                          SHAPE: 
CONSISTENCY:                                   SURFACE: 
CONTOUR:                                           MOBILITY: 
ADNEXAE: 
SPECULUM EXAMINATION: 
P/V EXAMINATION: 
INVESTIGATIONS: 
HAEMOGRAM – 
URINE – ALB, SUGAR, MICRO : 
BLOOD GROUPING RH TYPING : 
URINE C/S : 
THYROID FUNCTION TESTS : 
X– RAY CHEST : 
E.C.G : 
U.S.G : 
OTHER INVESTIGATIONS : 
CLINICAL DIAGNOSIS: 
HYSTEROSCOPY FINDINGS: 
CERVIX : 
ENDOCERVIX : 
ISTHMUS : 
ENDOMETRIAL CAVITY : 
ENDOMETRIUM : 
RIGHT CORNU : 
RIGHT TUBAL OSTIUM : 
LEFT CORNU : 
LEFT TUBAL OSTIUM : 
ENDOVAGINAL SONOGRAPHY 
THICKNESS OF THE ENDOMETRIUM 
PRESENCE OF CERVICAL / INTRA UTERINE LESIONS:        
DIMENSIONS: 
HISTOPATHOLOGICAL REPORT 
ABBREVIATION 
TVS - Transvaginal sonography 
HPE - Histopathological Examination 
AUB - Abnormal Uterine Bleeding 
D&C - Dilatation  and Curettage 
RCOG - Royal College of obstetricians and gynecologists 
ACOG - American College of obstetricians and gynecologists 
3D - 3 Dimension 
CO2 - Carbondioxide  
PPV - Positive predictive value 
NPV - Negative predictive value 
SIS - Saline infusion sonography 
PMB - Post menopausal bleeding 
HRT - Harmone replacement therapy 
BT - Bleeding time 
CT - Clotting time 
   
 
